Wegovy, specifically approved for obesity management, follows a titration ladder from 0.25 mg weekly to a maximum of 2.4 mg
Designed to complement medical treatment with sustainable behavior change, Pivot combines medication tracking, habit logging, and personalized insights into a single, structured experience
Dual GIP + GLP-1 agonist Member results A stronger next step for members who need better hunger control or fresh momentum
Clinical Evidence Behind Approval The FDAs decision to approve Zepbound was based on two large, randomized, double-blind, placebo-controlled studies involving adults with moderate to severe OSA
GSH, a tripeptide composed of glutamate, cysteine and glycine, is an important antioxidant in cells
Cancers 11